《亚洲股市》日、港及韩股跌幅扩至1.4%-1.6% 印尼及新西兰逆升0.5%
内地新冠肺炎确诊个案累增至72,436宗。美股期货全面跌0.3%-0.6%。亚太区股市午後普遍维持向下,日经跌幅扩大,最低见23,133,现造23,184,续跌1.4%。韩股跌幅扩至1.6%报2,206。台湾加权指数续吐近1%报11,651;印度孟买指数续跌0.8%报40,731。
恒指午後跌幅进一步扩大曾失守10天线(27,540),最低见27,496,现造27,552,回吐405或近1.5%。沪指及深成现造2,972及11,230,反覆回吐0.4%及0.1%。
印尼及新西兰股市逆市续升0.5%,分别报5,896及11,935。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.